Anthropometric Factors and Thyroid Cancer Risk by Histological Subtype: Pooled Analysis of 22 Prospective Studies
- PMID: 26756356
- PMCID: PMC4754509
- DOI: 10.1089/thy.2015.0319
Anthropometric Factors and Thyroid Cancer Risk by Histological Subtype: Pooled Analysis of 22 Prospective Studies
Abstract
Background: Greater height and body mass index (BMI) have been associated with an increased risk of thyroid cancer, particularly papillary carcinoma, the most common and least aggressive subtype. Few studies have evaluated these associations in relation to other, more aggressive histologic types or thyroid cancer-specific mortality.
Methods: This large pooled analysis of 22 prospective studies (833,176 men and 1,260,871 women) investigated thyroid cancer incidence associated with greater height, BMI at baseline and young adulthood, and adulthood BMI gain (difference between young-adult and baseline BMI), overall and separately by sex and histological subtype using multivariable Cox proportional hazards regression models. Associations with thyroid cancer mortality were investigated in a subset of cohorts (578,922 men and 774,373 women) that contributed cause of death information.
Results: During follow-up, 2996 incident thyroid cancers and 104 thyroid cancer deaths were identified. All anthropometric factors were positively associated with thyroid cancer incidence: hazard ratios (HR) [confidence intervals (CIs)] for height (per 5 cm) = 1.07 [1.04-1.10], BMI (per 5 kg/m2) = 1.06 [1.02-1.10], waist circumference (per 5 cm) = 1.03 [1.01-1.05], young-adult BMI (per 5 kg/m2) = 1.13 [1.02-1.25], and adulthood BMI gain (per 5 kg/m2) = 1.07 [1.00-1.15]. Associations for baseline BMI and waist circumference were attenuated after mutual adjustment. Baseline BMI was more strongly associated with risk in men compared with women (p = 0.04). Positive associations were observed for papillary, follicular, and anaplastic, but not medullary, thyroid carcinomas. Similar, but stronger, associations were observed for thyroid cancer mortality.
Conclusion: The results suggest that greater height and excess adiposity throughout adulthood are associated with higher incidence of most major types of thyroid cancer, including the least common but most aggressive form, anaplastic carcinoma, and higher thyroid cancer mortality. Potential underlying biological mechanisms should be explored in future studies.
Similar articles
-
Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer.Ann Oncol. 2020 Jan;31(1):103-114. doi: 10.1016/j.annonc.2019.09.007. Ann Oncol. 2020. PMID: 31912782 Free PMC article.
-
Body fat distribution, weight change during adulthood, and thyroid cancer risk in the NIH-AARP Diet and Health Study.Int J Cancer. 2012 Mar 15;130(6):1411-9. doi: 10.1002/ijc.26161. Epub 2011 Aug 2. Int J Cancer. 2012. PMID: 21544808 Free PMC article.
-
Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition.Int J Cancer. 2010 May 15;126(10):2404-15. doi: 10.1002/ijc.24952. Int J Cancer. 2010. PMID: 19821492
-
Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies.Ann Oncol. 2015 Aug;26(8):1635-48. doi: 10.1093/annonc/mdv142. Epub 2015 Mar 19. Ann Oncol. 2015. PMID: 25791635 Review.
-
Body shape index in comparison with other anthropometric measures in prediction of total and cause-specific mortality.J Epidemiol Community Health. 2016 Jan;70(1):90-6. doi: 10.1136/jech-2014-205257. Epub 2015 Jul 9. J Epidemiol Community Health. 2016. PMID: 26160362 Review.
Cited by
-
Association of Serum Progranulin Levels with Progression of Papillary Thyroid Cancer.Endocrinol Metab (Seoul). 2020 Jun;35(2):288-289. doi: 10.3803/EnM.2020.35.2.288. Epub 2020 Jun 24. Endocrinol Metab (Seoul). 2020. PMID: 32615712 Free PMC article. No abstract available.
-
Microbiota's role in health and diseases.Environ Sci Pollut Res Int. 2021 Jul;28(28):36967-36983. doi: 10.1007/s11356-021-14593-z. Epub 2021 May 27. Environ Sci Pollut Res Int. 2021. PMID: 34043164 Free PMC article. Review.
-
Transcriptome Analysis of Subcutaneous Adipose Tissue from Severely Obese Patients Highlights Deregulation Profiles in Coding and Non-Coding Oncogenes.Int J Mol Sci. 2021 Feb 17;22(4):1989. doi: 10.3390/ijms22041989. Int J Mol Sci. 2021. PMID: 33671464 Free PMC article.
-
Blood prognostic predictors of treatment response for patients with papillary thyroid cancer.Biosci Rep. 2020 Oct 30;40(10):BSR20202544. doi: 10.1042/BSR20202544. Biosci Rep. 2020. PMID: 33015713 Free PMC article.
-
The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis.Am J Transl Res. 2019 Sep 15;11(9):5888-5896. eCollection 2019. Am J Transl Res. 2019. PMID: 31632557 Free PMC article.
References
-
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. 2013. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer. Available at: http://globocan.iarc.fr (accessed April22, 2014)
-
- Ito Y, Nikiforov YE, Schlumberger M, Vigneri R. 2013. Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol 9:178–184 - PubMed
Publication types
MeSH terms
Grants and funding
- CA-40360/CA/NCI NIH HHS/United States
- HL-26490/HL/NHLBI NIH HHS/United States
- HHSN261201000140C/CA/NCI NIH HHS/United States
- HHSN261201000035C/CA/NCI NIH HHS/United States
- R01 CA082729/CA/NCI NIH HHS/United States
- UM1 CA173640/CA/NCI NIH HHS/United States
- K05-CA154337/CA/NCI NIH HHS/United States
- R37 CA070867/CA/NCI NIH HHS/United States
- CRUK_/Cancer Research UK/United Kingdom
- UM1 CA182913/CA/NCI NIH HHS/United States
- R01 CA77398/CA/NCI NIH HHS/United States
- CA-097193/CA/NCI NIH HHS/United States
- BHF_/British Heart Foundation/United Kingdom
- U58DP003862-01/DP/NCCDPHP CDC HHS/United States
- HL-34595/HL/NHLBI NIH HHS/United States
- Z01-ES-044005/ES/NIEHS NIH HHS/United States
- HHSN261201000034C/CA/NCI NIH HHS/United States
- MRC_/Medical Research Council/United Kingdom
- P30 CA013330/CA/NCI NIH HHS/United States
- 001/WHO_/World Health Organization/International
- UM1 CA182910/CA/NCI NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- CA-34933/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical